NASDAQ : PMN
ProMIS Neurosciences, Inc. — Financial statements
Healthcare · Biotechnology · Canada
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cost of Revenue | 35.66M | 33.38M | 10.64M | 7.88M | 16.09M | 4.63M |
| Gross Profit | -35.66M | -33.38M | -10.64M | -7.88M | -16.09M | -4.63M |
| Selling, General & Admin | 7.28M | 6.29M | 6.19M | 5.58M | 5.99M | 3.66M |
| Operating Expenses | 7.28M | 6.29M | 6.19M | 5.58M | 5.99M | 3.66M |
| Operating Income | -42.93M | -39.67M | -16.83M | -13.46M | -22.08M | -8.29M |
| Interest Expense | -76.78K | -201.39K | -282.06K | -416.29K | ||
| Other Non Operating Income (Expenses) | 1.21M | 448.16K | 23.18M | 1.25M | 4.29M | -1.08M |
| EBT Excluding Unusual Items | -41.73M | -39.22M | 6.28M | -12.41M | -18.07M | -9.79M |
| Other Unusual Items | -500.00K | -500.00K | -3.50M | -800.00K | 7.42K | |
| Pretax Income | -42.23M | -39.72M | 2.78M | -13.21M | -18.06M | -9.79M |
| Net Income | -42.23M | -39.72M | 2.78M | -13.21M | -18.06M | -9.79M |
| Net Income to Common | -42.23M | -39.72M | 2.78M | -13.21M | -18.06M | -9.79M |
| Shares Outstanding (Basic) | 5.00M | 1.76M | 1.04M | 491.71K | 300.10K | 231.43K |
| Shares Outstanding (Diluted) | 5.00M | 1.76M | 1.06M | 491.71K | 300.10K | 231.43K |
| EPS (Basic) | -8.45 | -22.61 | 2.68 | -26.87 | -60.19 | -42.30 |
| EPS (Diluted) | -8.45 | -22.61 | 2.63 | -26.87 | -60.19 | -42.30 |
| Free Cash Flow | -42.11M | -28.12M | -27.18M | -10.84M | -17.04M | -9.31M |
| Free Cash Flow Per Share | -8.43 | -16.00 | -25.68 | -22.05 | -56.77 | -40.23 |
| EBITDA | -16.81M | -13.44M | -22.07M | -8.25M | ||
| D&A For EBITDA | 21.16K | 21.16K | 11.22K | 45.83K | ||
| EBIT | -42.93M | -39.67M | -16.83M | -13.46M | -22.08M | -8.29M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 53.43M | 6.12M | 13.29M | 12.60M | 5.88M | 16.94M |
| Short-Term Investments | 33.75K | 33.75K | 33.05K | 32.36K | 43.92K | 40.09K |
| Cash & Short-Term Investments | 53.46M | 6.15M | 13.32M | 12.63M | 5.92M | 16.98M |
| Other Receivables | 215.23K | 36.52K | 78.03K | 78.64K | 71.63K | 48.69K |
| Receivables | 215.23K | 36.52K | 78.03K | 78.64K | 71.63K | 48.69K |
| Prepaid Expenses | 125.78K | 300.06K | 374.23K | 534.30K | 561.51K | 122.52K |
| Other Current Assets | 2.89M | 2.70M | 5.13M | 375.70K | 350.64K | 559.26K |
| Total Current Assets | 56.69M | 9.18M | 18.91M | 13.62M | 6.90M | 17.71M |
| Property, Plant & Equipment | 321.00 | 4.67K | ||||
| Other Intangible Assets | 20.84K | 27.61K | ||||
| Total Assets | 56.69M | 9.18M | 18.91M | 13.62M | 6.92M | 17.75M |
| Accounts Payable | 1.79M | 2.54M | 1.74M | 7.84M | 2.98M | 408.98K |
| Accrued Expenses | 5.42M | 7.87M | 480.96K | 1.51M | 3.44M | 520.09K |
| Total Current Liabilities | 7.22M | 10.41M | 2.22M | 9.35M | 6.41M | 929.07K |
| Long-Term Debt | 3.91M | |||||
| Other Long-Term Liabilities | 77.25K | 29.18K | 204.85K | 516.19K | 1.86M | 7.25M |
| Total Liabilities | 7.29M | 10.44M | 2.42M | 9.87M | 8.27M | 12.09M |
| Additional Paid-In Capital | 200.15M | 129.52M | 107.55M | 97.59M | 79.10M | 68.04M |
| Retained Earnings | -150.38M | -130.41M | -90.69M | -93.47M | -80.25M | -62.19M |
| Comprehensive Income & Other | -371.18K | -371.18K | -371.18K | -371.18K | -195.37K | -187.92K |
| Shareholders' Equity | 49.40M | -1.26M | 16.49M | 3.75M | -1.35M | 5.66M |
| Total Liabilities & Equity | 56.69M | 9.18M | 18.91M | 13.62M | 6.92M | 17.75M |
| Total Debt | 3.91M | |||||
| Net Cash (Debt) | 53.46M | 6.15M | 13.32M | 12.63M | 5.92M | 13.08M |
| Net Cash Per Share | 10.70 | 3.50 | 12.59 | 25.69 | 19.73 | 56.51 |
| Filing Date Shares Outstanding | 8.97M | 8.97M | 1.31M | 758.45K | 343.17K | 287.82K |
| Total Common Shares Outstanding | 8.97M | 2.15M | 1.31M | 755.41K | 343.17K | 287.82K |
| Working Capital | 49.48M | -1.23M | 16.69M | 4.27M | 490.44K | 16.79M |
| Book Value Per Share | 5.51 | -0.58 | 12.61 | 4.97 | -3.93 | 19.67 |
| Tangible Book Value | 49.40M | -1.26M | 16.49M | 3.75M | -1.37M | 5.63M |
| Tangible Book Value Per Share | 5.51 | -0.58 | 12.61 | 4.97 | -3.99 | 19.57 |
| Machinery | 84.06K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -42.23M | -39.72M | 2.78M | -13.21M | -18.06M | -9.79M |
| Depreciation & Amortization | 21.16K | 11.22K | 45.83K | |||
| Other Amortization | 241.85K | 366.02K | ||||
| Loss (Gain) From Sale of Assets | -59.16K | |||||
| Stock-Based Compensation | 998.64K | 857.63K | 825.81K | 271.54K | 487.63K | 515.63K |
| Other Operating Activities | -5.59K | -5.59K | -19.06M | -868.55K | -5.11M | 1.18M |
| Change in Accounts Payable | -986.70K | 805.95K | -6.11M | 4.96M | 2.68M | -31.65K |
| Change in Other Net Operating Assets | 115.79K | 9.94M | -5.62M | -2.02M | 2.73M | -1.53M |
| Operating Cash Flow | -42.11M | -28.12M | -27.18M | -10.84M | -17.03M | -9.31M |
| Capital Expenditures | -1.98K | -6.04K | ||||
| Sale of Property, Plant & Equipment | 98.33K | |||||
| Investment in Securities | -702.00 | -702.00 | -693.00 | -1.35K | 2.33K | |
| Investing Cash Flow | -702.00 | -702.00 | -693.00 | -1.35K | -1.98K | 94.62K |
| Long-Term Debt Issued | 6.92M | |||||
| Total Debt Issued | 6.92M | |||||
| Net Debt Issued (Repaid) | 6.92M | |||||
| Issuance of Common Stock | 80.16M | 10.08M | 27.88M | 17.75M | 4.97M | 15.87M |
| Other Financing Activities | 10.87M | 10.87M | 1.52M | 2.74M | ||
| Financing Cash Flow | 91.03M | 20.94M | 27.88M | 17.75M | 6.49M | 25.52M |
| Foreign Exchange Rate Adjustments | -181.43K | -526.90K | -175.02K | |||
| Net Cash Flow | 48.92M | -7.17M | 693.02K | 6.72M | -11.07M | 16.14M |
| Free Cash Flow | -42.11M | -28.12M | -27.18M | -10.84M | -17.04M | -9.31M |
| Free Cash Flow Per Share | -8.43 | -16.00 | -25.68 | -22.05 | -56.77 | -40.23 |
| Levered Free Cash Flow | -26.84M | -13.32M | -21.47M | -5.32M | -8.01M | -6.11M |
| Unlevered Free Cash Flow | -26.84M | -13.32M | -21.42M | -5.19M | -8.07M | -6.22M |
| Cash Interest Paid | 76.78K | 201.39K | ||||
| Change in Working Capital | -870.92K | 10.75M | -11.73M | 2.94M | 5.40M | -1.56M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 26.90M | 14.69M | 30.98M | 21.72M | 37.23M | 49.17M |
| Enterprise Value | -26.56M | -741.79K | 9.41M | 4.80M | 33.27M | 31.98M |
| Last Close Price | 3.00 | 6.83 | 23.70 | 28.75 | 108.50 | 170.85 |
| PE Ratio | 11.15 | |||||
| PB Ratio | 0.54 | -11.67 | 1.88 | 5.79 | -27.63 | 8.69 |
| P/TBV Ratio | 0.54 | 1.88 | 5.79 | 8.73 | ||
| Debt / Equity Ratio | 0.69 | |||||
| Net Debt / Equity Ratio | -1.08 | 4.89 | -0.81 | -3.37 | 4.39 | -2.31 |
| Net Debt / EBITDA Ratio | 0.79 | 0.94 | 0.27 | 1.59 | ||
| Net Debt / FCF Ratio | 1.27 | 0.22 | 0.49 | 1.17 | 0.35 | 1.41 |
| Quick Ratio | 7.44 | 0.59 | 6.04 | 1.36 | 0.93 | 18.33 |
| Current Ratio | 7.86 | 0.88 | 8.53 | 1.46 | 1.08 | 19.07 |
| Return on Equity (ROE) | -172.30% | -521.61% | 27.46% | -1,098.51% | -837.71% | -403.11% |
| Return on Assets (ROA) | -81.06% | -176.49% | -64.66% | -81.92% | -111.87% | -55.01% |
| Return on Capital Employed (ROCE) | -86.80% | 3,226.50% | -100.80% | -315.30% | -4,315.80% | -49.30% |
| Earnings Yield | -281.71% | -270.37% | 8.97% | -60.84% | -48.51% | -19.91% |
| FCF Yield | -156.51% | -191.41% | -87.73% | -49.93% | -45.75% | -18.94% |
| Buyback Yield / Dilution | -272.11% | -65.98% | -115.26% | -63.85% | -29.68% | -21.55% |